Shangqing Song
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
-
- Renal cell carcinoma treatment 3
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 3
- Epigenetics and DNA Methylation 2
- Renal and related cancers 2
-
- IL-33, ST2, and ILC Pathways 2
- Partner nations
- ChinaGermanySouth Korea
In The Last Decade
Shangqing Song
15 papers receiving 482 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 172
- Pulmonary and Respiratory Medicine 201
- Molecular Biology 290
- Neurology 28
- Health Informatics 3
Countries citing papers authored by Shangqing Song
This map shows the geographic impact of Shangqing Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangqing Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangqing Song more than expected).
Fields of papers citing papers by Shangqing Song
This network shows the impact of papers produced by Shangqing Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangqing Song. The network helps show where Shangqing Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shangqing Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 57 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 38 | |
| 6 | 2020 | 23 | |
| 7 | 2019 | 88 | |
| 8 | 2018 | 21 | |
| 9 | 2017 | 19 | |
| 10 | 2015 | 0 | |
| 11 | 2014 | 97 | |
| 12 | 2014 | 33 | |
| 13 | 2014 | 34 | |
| 14 | 2013 | 10 | |
| 15 | 2011 | 45 | |
| 16 | 2001 | 15 |
About Shangqing Song
Shangqing Song is a scholar working on Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 488 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers), RNA modifications and cancer (3 papers), Circular RNAs in diseases (3 papers), Epigenetics and DNA Methylation (2 papers), Renal and related cancers (2 papers), Cancer, Lipids, and Metabolism (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (172 citations), Pulmonary and Respiratory Medicine (201 citations) and Molecular Biology (290 citations). Shangqing Song has collaborated with scholars based in China, Germany and South Korea. Frequent co-authors include Linhui Wang, Guopeng Yu, Zhenjie Wu, Huamao Ye, Zhong Wang, Qing Yang, Xiao Liang, Qing Yang, Mingmin Li and Bing Liu. Their work appears in journals such as PLoS ONE, European Heart Journal and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.